From the Globe and Mail:
Proposal may speed drug approvals, group says
Canada's generic drug makers say a proposal to put pharmacare in federal hands could streamline the process of bringing their products to market, reducing pharmaceutical costs.

Jim Keon, president of the Canadian Generic Pharmaceutical Association, said there are obvious financial incentives for Ottawa to get cheaper generic drugs on the shelves faster if it is paying the bill.